famotidine has been researched along with Cancer of Sigmoid in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimoda, K | 1 |
| Hazama, S | 1 |
| Mitsunaga, H | 1 |
| Uchiyama, T | 1 |
| Oka, M | 1 |
| Suzuki, T | 1 |
1 other study available for famotidine and Cancer of Sigmoid
| Article | Year |
|---|---|
[A case of recurrent pelvic tumor of sigmoid colon cancer showing partial response to lipiodolization].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Combined Modality Th | 1991 |